Connect Biopharma Holdings logo

CNTB - Connect Biopharma Holdings News Story

$26 1.0  4.0%

Last Trade - 23/07/21

Mid Cap
Market Cap £1.06bn
Enterprise Value £1.29bn
Revenue £n/a
Position in Universe 2543rd / 6998

BRIEF-Connect Biopharma Announces First Subject Dosed In Phase I Trial Evaluating Safety, Tolerability And Pharmacokinetic Profile Of CBP-174 In Healthy Adult Subjects

Tue 25th May, 2021 1:15pm
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.